Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La RochefiledCriticalHoffmann La Roche
Publication of MX9606354ApublicationCriticalpatent/MX9606354A/es
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describe una formulacion de tableta sublingual que contiene querotolac en la forma de una sal farmacéuticamente aceptable, en particular la sal de trometamina. La formulacion es bioequivalente a otras formas de dosificacion oral convencionales de querotolac, y tiene la ventaja de que se absorbe mucho más rápidamente la sustancia activa contenida en la formulacion.
MX9606354A1996-11-061996-12-11Formulacion sublingual de querotolac.
MX9606354A
(es)
Stable extended release oral dosage composition comprising a pseudoephedrine-containing core, the core being uniformly covered with a desloratadine-containing film